Global Fertility Network (GFN) has completed its second major acquisition in Saudi Arabia this year, purchasing a controlling stake in HealthPlus Fertility Center in Jeddah for integration into its expanding regional network. The transaction represents part of a broader 100 million Saudi Riyal (US$27 million) investment strategy aimed at establishing the largest fertility services network in the Kingdom and wider Gulf Cooperation Council region.
Strategic consolidation targets growing demand
The acquisition follows GFN’s earlier purchase of Bnoon IVF Center in Riyadh, with both facilities now operating under the unified Bnoon brand. This consolidation has effectively doubled the network’s treatment capacity to over 5,000 IVF cycles annually, positioning GFN as the largest standalone assisted reproductive technology provider in Saudi Arabia.
Both acquired centres were previously part of M42’s healthcare portfolio between 2022 and 2024, indicating continued consolidation within the regional fertility sector. The expansion strategy extends beyond acquisitions, with a 3,800-square-metre flagship facility currently under construction in northern Riyadh, scheduled to open in December 2025.
“The expansion in Saudi Arabia is part of GFN’s broader strategy to establish a regional platform of fertility and women’s health centres,” said Majd Abu Zant, founder and CEO of Global Fertility Network. “Under the Bnoon name, GFN brings together some of the leading Saudi IVF consultants with decades of clinical experience, supported by state-of-the-art IVF laboratories designed to deliver the highest standards in reproductive care.”
Investment backing enables rapid expansion
The growth trajectory is supported by approximately $60 million in equity financing from institutional investors and family offices across Saudi Arabia and the UAE. Dubai Investments, listed on the Dubai Financial Market, has acquired a 34.3% equity stake in the network, providing substantial backing for continued expansion.
Additional facilities are planned for Khobar, Abha, and other Saudi cities as part of the network’s regional development strategy. The approach reflects broader healthcare sector trends towards consolidation and standardisation of specialised medical services.
Clinical demand drives market expansion
Regional fertility specialists cite increasing demand for assisted reproductive technologies across the Gulf region. Dr Abdulaziz Muhammad AlShahrani, group medical director at Bnoon and founder of the original Riyadh facility, noted rising numbers of couples seeking treatment for both primary and secondary infertility.
“We’re seeing a noticeable increase in couples seeking fertility treatment, driven by both primary and secondary infertility,” AlShahrani said. “With growing awareness, more individuals are also considering fertility treatments to help balance their families and prevent genetic diseases.”
Dr Fawaz Adeeb Edris, executive director at the Jeddah facility, highlighted demographic factors contributing to increased service demand. “Studies show that fertility rates across the GCC have steadily declined, while infertility affects around 15% of couples, or more, fueling a sharp rise in demand for fertility services,” he said.
Contributing factors include delayed parenthood, socioeconomic pressures, obesity, polycystic ovary syndrome, and male fertility issues, according to clinical observations from the network’s practitioners.
Technology integration supports clinical outcomes
The consolidated network emphasises integration of advanced medical technologies, artificial intelligence, and data-driven approaches to enhance treatment protocols and accessibility. This technological focus aligns with Saudi Arabia’s Vision 2030 healthcare innovation objectives, supporting the Kingdom’s broader healthcare sector development goals.
